457 results
8-K
LCTX
Lineage Cell Therapeutics Inc
14 Jun 24
Changes in Registrant's Certifying Accountant
5:00pm
in Registrant’s Certifying Accountant.
(a) Previous Independent Registered Public Accounting Firm
On June 11, 2024, the Audit Committee … independent registered public accounting firm, effective on that date. Withum audited the Company’s consolidated financial statements for the years ended
8-K
EX-3.1
LCTX
Lineage Cell Therapeutics Inc
13 Jun 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
as an “independent” director or “audit committee financial expert” for purposes of membership of the Board of Directors or any committee thereof under … to determine the eligibility of such proposed Nominee to serve as an “independent” director of the Corporation under the rules of the principal national
8-K
LCTX
Lineage Cell Therapeutics Inc
13 Jun 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
C. Russell
2.Shareholders ratified the appointment of WithumSmith+Brown, PC as the Company’s independent registered public accounting firm
8-K
EX-3.1
LCTX
Lineage Cell Therapeutics Inc
13 Jun 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
to the Corporation and its shareholders; (G) whether such NomineesNominee qualifies as an “independent” director or “audit committee financial expert … to determine the eligibility of such proposed Nominee to serve as an “independent” director of the Corporation under the rules of the principal national
424B5
LCTX
Lineage Cell Therapeutics Inc
14 May 24
Prospectus supplement for primary offering
4:36pm
pursuant to approval by the independent members of our board of directors in reliance the exception for inducement grants to new employees under the NYSE … plans or outside of our equity incentive plans pursuant to approval by the independent members of our board of directors in reliance the exception
DEFA14A
5ji20mh1th qay6z
29 Apr 24
Additional proxy soliciting materials
4:40pm
424B5
gxw1oty hqfff32cdkr
22 Mar 24
Prospectus supplement for primary offering
4:32pm
8-K
EX-1.1
roac0es
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
424B5
56mlm47z
6 Feb 24
Prospectus supplement for primary offering
9:25am
8-K
EX-10.1
mu94zaj pzrry2b
6 Feb 24
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
9:20am
S-8
EX-5.1
fyu7g
13 Nov 23
Registration of securities for employees
4:19pm